Literature DB >> 27377178

Acute Lower Limb Ischaemia and Diabetes in a Patient Treated with Anti-PD1 Monoclonal Antibody for Metastatic Melanoma.

Benjamin Thoreau1, Flora Gouaillier-Vulcain, Laurent Machet, Christine Mateus, Caroline Robert, Nicole Ferreira-Maldent, François Maillot, Bertrand Lioger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27377178     DOI： 10.2340/00015555-2504

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  8 in total

Review 1.  Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus?

Authors:  Angelos Kyriacou; Eka Melson; Wentin Chen; Punith Kempegowda
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

Review 2.  Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.

Authors:  Lee-Shing Chang; Romualdo Barroso-Sousa; Sara M Tolaney; F Stephen Hodi; Ursula B Kaiser; Le Min
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 3.  Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.

Authors:  Meng H Tan; Ravi Iyengar; Kara Mizokami-Stout; Sarah Yentz; Mark P MacEachern; Li Yan Shen; Bruce Redman; Roma Gianchandani
Journal:  Clin Diabetes Endocrinol       Date:  2019-01-22

4.  Acral vascular syndrome during an immune checkpoint inhibitor.

Authors:  Patrick O'Connor; Pooja Bhadbhade; Qamar Khan; Stephen Williamson
Journal:  BMJ Case Rep       Date:  2020-05-17

5.  Anti-PD-1 pembrolizumab induced autoimmune diabetes in Chinese patient: A case report.

Authors:  Sicheng Li; Yi Zhang; Zhichun Sun; Ji Hu; Chen Fang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

6.  Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review.

Authors:  Jeroen M K de Filette; Joeri J Pen; Lore Decoster; Thomas Vissers; Bert Bravenboer; Bart J Van der Auwera; Frans K Gorus; Bart O Roep; Sandrine Aspeslagh; Bart Neyns; Brigitte Velkeniers; Aan V Kharagjitsingh
Journal:  Eur J Endocrinol       Date:  2019-09       Impact factor: 6.664

7.  Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival.

Authors:  Tamara A Sussman; Hong Li; Brian Hobbs; Pauline Funchain; Keith R McCrae; Alok A Khorana
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 12.469

Review 8.  Sintilimab induced diabetic ketoacidosis in a patient with small cell lung cancer: A case report and literature review.

Authors:  Xiaofei Huang; Mei Yang; Liu Wang; Libo Li; Xiaowei Zhong
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.